When.com Web Search

  1. Ads

    related to: metformin alzheimer's clinical trial

Search results

  1. Results From The WOW.Com Content Network
  2. Metformin - Wikipedia

    en.wikipedia.org/wiki/Metformin

    Preliminary studies have examined whether metformin can reduce the risk of Alzheimer's disease and whether there is a correlation between type 2 diabetes and the risk of Alzheimer's disease. [248] [249] While metformin may reduce body weight in persons with fragile X syndrome, whether it improves neurological or psychiatric symptoms is uncertain.

  3. Could a cancer drug help treat early Alzheimer’s? Study ...

    www.aol.com/could-cancer-drug-help-treat...

    Treatment with the cancer drug restored function in the hippocampus in an Alzheimer's mouse model. ... MNT he would be pleased to see clinical trials for metabolic ... from using metformin ...

  4. Semaglutide drugs may help keep Alzheimer's at bay - AOL

    www.aol.com/semaglutide-drugs-may-help-keep...

    People with type 2 diabetes who use semaglutide drugs like Ozempic and Wegovy appear to have a lower risk of Alzheimer's disease, new evidence shows. ... including metformin and the first ...

  5. The Surprising Medication That May Lower Your Risk of Alzheimer's

    www.aol.com/surprising-medication-may-lower-risk...

    Science & Tech. Shopping. Sports

  6. Nir Barzilai - Wikipedia

    en.wikipedia.org/wiki/Nir_Barzilai

    These genes appear to protect centenarians against major age-related diseases, such as cardiovascular disease, cancer, type 2 diabetes and dementia. [10] Treatments for age-related diseases were under development based on Barzilai’s work. A collaboration with Merck conducted early-stage clinical trials but ultimately abandoned Anacetrapib.

  7. Alzheon - Wikipedia

    en.wikipedia.org/wiki/Alzheon

    Alzheon was founded in July 2013 by Martin Tolar, MD, PhD, a veteran of Alzheimer's drug programs, [2] who serves as president and CEO of the organization. [3] Alzheon completed a $10 million Series A round of financing in April 2015 [4] [5] and started the Phase lb bridging clinical program for ALZ-801, which was completed in July 2016.

  1. Ads

    related to: metformin alzheimer's clinical trial